GlassScriptPhysician profile
Price Sonkarley
NPI 1396159661
$4,399.20
in general payments reported to CMS, 2019-2025
18 companies · $600 in 2025
The $600 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $533 · 2020: $376 · 2021: $661 · 2022: $547 · 2023: $1,073 · 2024: $610 · 2025: $600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,996 · Travel and Lodging: $231 · Education: $56.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,996.22 |
| Travel and Lodging | $230.68 |
| Education | $56.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $769.66 | 2022-2025 | Propel, Stealth Autoguide System, Stealthstation S8 Platform |
| Regeneron Healthcare Solutions, INC. | $710.06 | 2020-2025 | Dupixent |
| Genzyme Corporation | $590.96 | 2019-2025 | |
| Stryker Corporation | $527.49 | 2019-2025 | Fiagon Navigation Unit, Xpress Loprofile |
| Glaxosmithkline, LLC. | $486.08 | 2019-2025 | Nucala |
| Optinose US, INC. | $432.27 | 2019-2025 | |
| Intersect Ent, INC. | $301.67 | 2019-2021 | |
| Genentech USA, INC. | $200.31 | 2019-2021 | |
| Kaleo, INC. | $96.45 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $58.73 | 2019-2022 | |
| Aerin Medical INC. | $55.62 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $38.95 | 2020-2021 | |
| Olympus America INC. | $30.84 | 2023 | |
| Merck Sharp & Dohme LLC | $25.08 | 2023 | |
| Baudax Bio INC. | $24.77 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $24.41 | 2025 | Xhance |
| Integra Lifesciences Corporation | $14.32 | 2022 | |
| Galderma Laboratories, L.P. | $11.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Price Sonkarley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.